One of the roles of HIF1α is up-regulating EZH2 expression under hypoxia in breast tumor initiating cells (BTICs) that contribute to cancer progression; HIF inhibitors may potentially be effective in suppressing EZH2 oncogenic function in these cells to prevent cancer recurrence [43]. The gene discussed is EZH2; the disease is breast neoplasm.